Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

1.

Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial.

Eriksson M, Budinski D, Hounslow N.

Adv Ther. 2011 Sep;28(9):811-23. doi: 10.1007/s12325-011-0056-7. Epub 2011 Aug 25.

PMID:
21874538
[PubMed - indexed for MEDLINE]
2.

Long-term efficacy of pitavastatin versus simvastatin.

Eriksson M, Budinski D, Hounslow N.

Adv Ther. 2011 Sep;28(9):799-810. doi: 10.1007/s12325-011-0057-6. Epub 2011 Aug 25.

PMID:
21874537
[PubMed - indexed for MEDLINE]
3.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
[PubMed - indexed for MEDLINE]
4.

A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.

Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY.

Clin Ther. 2005 Jul;27(7):1074-82.

PMID:
16154486
[PubMed - indexed for MEDLINE]
5.

Pitavastatin: clinical effects from the LIVES Study.

Teramoto T.

Atheroscler Suppl. 2011 Nov;12(3):285-8. doi: 10.1016/S1567-5688(11)70888-1. Review.

PMID:
22152283
[PubMed - indexed for MEDLINE]
6.

Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.

Strandberg TE, Feely J, Sigurdsson EL; DISCOVERY study group.

Clin Ther. 2004 Nov;26(11):1821-33.

PMID:
15639694
[PubMed - indexed for MEDLINE]
7.

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.

Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.

Clin Ther. 2007 Nov;29(11):2365-73.

PMID:
18158077
[PubMed - indexed for MEDLINE]
8.

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.

Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA; Simvastatin/Thiazolidinedione Study Group.

Clin Ther. 2004 Mar;26(3):379-89.

PMID:
15110130
[PubMed - indexed for MEDLINE]
9.

A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.

Olsson AG, Eriksson M, Johnson O, Kjellström T, Lanke J, Larsen ML, Pedersen T, Tikkanen MJ, Wiklund O; 3T Study Investigators.

Clin Ther. 2003 Jan;25(1):119-38.

PMID:
12637115
[PubMed - indexed for MEDLINE]
10.

Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.

Gumprecht J, Gosho M, Budinski D, Hounslow N.

Diabetes Obes Metab. 2011 Nov;13(11):1047-55. doi: 10.1111/j.1463-1326.2011.01477.x.

PMID:
21812889
[PubMed - indexed for MEDLINE]
11.

Pitavastatin - results from phase III & IV.

Betteridge J.

Atheroscler Suppl. 2010 Dec;11(3):8-14. doi: 10.1016/S1567-5688(10)71064-3. Review.

PMID:
21193153
[PubMed - indexed for MEDLINE]
12.

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia.

Saito Y, Yamada N, Teramoto T, Itakura H, Hata Y, Nakaya N, Mabuchi H, Tushima M, Sasaki J, Ogawa N, Goto Y.

Atherosclerosis. 2002 Jun;162(2):373-9. Erratum in: Atherosclerosis. 2003 Jun;168(2):401.

PMID:
11996957
[PubMed - indexed for MEDLINE]
13.

Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia.

Ose L, Budinski D, Hounslow N, Arneson V.

Atherosclerosis. 2010 May;210(1):202-8. doi: 10.1016/j.atherosclerosis.2009.12.009. Epub 2009 Dec 11. Erratum in: Atherosclerosis. 2010 Oct;212(2):704.

PMID:
20080236
[PubMed - indexed for MEDLINE]
14.

Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.

Karas RH, Kashyap ML, Knopp RH, Keller LH, Bajorunas DR, Davidson MH.

Am J Cardiovasc Drugs. 2008;8(2):69-81.

PMID:
18422390
[PubMed - indexed for MEDLINE]
15.

Pitavastatin: a review of its use in the management of hypercholesterolaemia or mixed dyslipidaemia.

Duggan ST.

Drugs. 2012 Mar 5;72(4):565-84. doi: 10.2165/11207180-000000000-00000. Review.

PMID:
22356292
[PubMed - indexed for MEDLINE]
16.

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.

Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.

Clin Ther. 2008 Jun;30(6):1089-101. doi: 10.1016/j.clinthera.2008.05.017.

PMID:
18640465
[PubMed - indexed for MEDLINE]
17.

Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia.

Sansanayudh N, Wongwiwatthananukit S, Putwai P, Dhumma-Upakorn R.

Ann Pharmacother. 2010 Mar;44(3):415-23. doi: 10.1345/aph.1M522. Epub 2010 Feb 23.

PMID:
20179259
[PubMed - indexed for MEDLINE]
18.

Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.

Wu CC, Sy R, Tanphaichitr V, Hin AT, Suyono S, Lee YT.

J Formos Med Assoc. 2002 Jul;101(7):478-87.

PMID:
12353340
[PubMed - indexed for MEDLINE]
19.

Pitavastatin calcium: clinical review of a new antihyperlipidemic medication.

Yee LL, Wright EA.

Clin Ther. 2011 Aug;33(8):1023-42. doi: 10.1016/j.clinthera.2011.07.011. Epub 2011 Aug 4. Review.

PMID:
21816477
[PubMed - indexed for MEDLINE]
20.

Pitavastatin - from clinical trials to clinical practice.

Masana L.

Atheroscler Suppl. 2010 Dec;11(3):15-22. doi: 10.1016/S1567-5688(10)71065-5. Review.

PMID:
21193154
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk